{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:23:06Z","timestamp":1793215386323,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02490-0","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:56:50Z","timestamp":1743044210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Arachidonic acid suppresses lung cancer cell growth and modulates lipid metabolism and the ERK\/PPAR\u03b3 signaling pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"3","key":"2490_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2490_CR2","doi-asserted-by":"crossref","unstructured":"Nooreldeen R, Bach H. Current and Future Development in Lung Cancer diagnosis. Int J Mol Sci, 2021. 22(16).","DOI":"10.3390\/ijms22168661"},{"issue":"10066","key":"2490_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299\u2013311.","journal-title":"Lancet"},{"key":"2490_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","volume":"102","author":"GY Ho","year":"2016","unstructured":"Ho GY, Woodward N, Coward JI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol. 2016;102:37\u201346.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2490_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.lungcan.2019.07.010","volume":"135","author":"F Griesinger","year":"2019","unstructured":"Griesinger F, et al. Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: a meta-analysis. Lung Cancer. 2019;135:196\u2013204.","journal-title":"Lung Cancer"},{"key":"2490_CR6","doi-asserted-by":"crossref","unstructured":"Attili I et al. New generations of tyrosine kinase inhibitors in treating NSCLC with Oncogene Addiction: strengths and limitations. Cancers (Basel), 2023. 15(20).","DOI":"10.3390\/cancers15205079"},{"issue":"8","key":"2490_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-022-00639-9","volume":"19","author":"AJ Cooper","year":"2022","unstructured":"Cooper AJ, Sequist LV, Lin JJ. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. Nat Rev Clin Oncol. 2022;19(8):499\u2013514.","journal-title":"Nat Rev Clin Oncol"},{"key":"2490_CR8","doi-asserted-by":"publisher","first-page":"153402","DOI":"10.1016\/j.phymed.2020.153402","volume":"80","author":"YQ Liu","year":"2021","unstructured":"Liu YQ, et al. Protection against chemotherapy- and radiotherapy-induced side effects: a review based on the mechanisms and therapeutic opportunities of phytochemicals. Phytomedicine. 2021;80:153402.","journal-title":"Phytomedicine"},{"issue":"suppl1","key":"2490_CR9","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","volume":"29","author":"D Westover","year":"2018","unstructured":"Westover D, et al. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors. Ann Oncol. 2018;29(suppl_1):i10\u20139.","journal-title":"Ann Oncol"},{"key":"2490_CR10","doi-asserted-by":"crossref","unstructured":"Koulouris A et al. Resistance to TKIs in EGFR-Mutated Non-small Cell Lung Cancer: from mechanisms to new therapeutic strategies. Cancers (Basel), 2022. 14(14).","DOI":"10.3390\/cancers14143337"},{"issue":"1","key":"2490_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11684-019-0735-3","volume":"15","author":"Y Fan","year":"2021","unstructured":"Fan Y, et al. Advances on immune-related adverse events associated with immune checkpoint inhibitors. Front Med. 2021;15(1):33\u201342.","journal-title":"Front Med"},{"issue":"2","key":"2490_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"key":"2490_CR13","doi-asserted-by":"crossref","unstructured":"Tallima H, El R, Ridi. Arachidonic acid: physiological roles and potential health benefits - a review. J Adv Res. 2018;11:33\u201341.","DOI":"10.1016\/j.jare.2017.11.004"},{"key":"2490_CR14","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1182\/blood-2019-131906","volume":"134","author":"C Panaroni","year":"2019","unstructured":"Panaroni C, et al. Polyunsaturated fatty acid (PUFA) signaling induces ferroptosis-mediated cell-death in multiple myeloma. Blood. 2019;134:3108.","journal-title":"Blood"},{"issue":"3","key":"2490_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0304-3835(91)90008-6","volume":"56","author":"UN Das","year":"1991","unstructured":"Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett. 1991;56(3):235\u201343.","journal-title":"Cancer Lett"},{"key":"2490_CR16","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1182\/blood-2018-99-118482","volume":"132","author":"C Panaroni","year":"2018","unstructured":"Panaroni C, et al. Arachidonic acid induces ferroptosis-mediated cell-death in multiple myeloma. Blood. 2018;132:4498.","journal-title":"Blood"},{"key":"2490_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1476-511X-10-159","volume":"10","author":"UN Das","year":"2011","unstructured":"Das UN, Madhavi N. Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis. 2011;10:159.","journal-title":"Lipids Health Dis"},{"key":"2490_CR18","doi-asserted-by":"crossref","unstructured":"Zhang N et al. Arachidonic acid regulation of Intracellular Signaling pathways and Target Gene expression in bovine ovarian granulosa cells. Anim (Basel), 2019. 9(6).","DOI":"10.3390\/ani9060374"},{"issue":"2","key":"2490_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1124\/dmd.123.001463","volume":"52","author":"H Jia","year":"2024","unstructured":"Jia H, et al. Deciphering the role of fatty acid-metabolizing CYP4F11 in Lung Cancer and its potential as a drug target. Drug Metab Dispos. 2024;52(2):69\u201379.","journal-title":"Drug Metab Dispos"},{"issue":"Database issue","key":"2490_CR20","first-page":"D684","volume":"36","author":"M Kuhn","year":"2008","unstructured":"Kuhn M, et al. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res. 2008;36(Database issue):D684\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"2490_CR21","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, et al. SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014;42(Web Server issue):W32\u20138.","journal-title":"Nucleic Acids Res"},{"key":"2490_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13.","journal-title":"J Cheminform"},{"key":"2490_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semcancer.2016.02.001","volume":"40\u201341","author":"NS Yarla","year":"2016","unstructured":"Yarla NS, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016;40\u201341:48\u201381.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2490_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2490_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4\u201322.","journal-title":"Br J Cancer"},{"issue":"3","key":"2490_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10(3):181\u201393.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2490_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"1","key":"2490_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12944-021-01599-2","volume":"20","author":"MA Vaezi","year":"2021","unstructured":"Vaezi MA, et al. 15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: a double-edged sword. Lipids Health Dis. 2021;20(1):169.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2490_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"1","key":"2490_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12672-023-00857-2","volume":"15","author":"BN Forgie","year":"2024","unstructured":"Forgie BN, et al. Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs? Discov Oncol. 2024;15(1):5.","journal-title":"Discov Oncol"},{"issue":"3","key":"2490_CR31","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007.","journal-title":"Exp Ther Med"},{"issue":"3","key":"2490_CR32","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/0006-291X(92)91891-S","volume":"182","author":"H Owaki","year":"1992","unstructured":"Owaki H, et al. Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs. Biochem Biophys Res Commun. 1992;182(3):1416\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2490_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12(1):9\u201318.","journal-title":"Cell Res"},{"key":"2490_CR34","doi-asserted-by":"publisher","first-page":"112319","DOI":"10.1016\/j.intimp.2024.112319","volume":"135","author":"Y Ren","year":"2024","unstructured":"Ren Y, et al. A novel insight into cancer therapy: lipid metabolism in tumor-associated macrophages. Int Immunopharmacol. 2024;135:112319.","journal-title":"Int Immunopharmacol"},{"key":"2490_CR35","doi-asserted-by":"crossref","unstructured":"Fu Y et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm (2020), 2021. 2(1): pp. 27\u201359.","DOI":"10.1002\/mco2.27"},{"key":"2490_CR36","doi-asserted-by":"publisher","first-page":"1274335","DOI":"10.3389\/fphar.2023.1274335","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang Z, et al. Lipid metabolism as a target for cancer drug resistance: progress and prospects. Front Pharmacol. 2023;14:1274335.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2490_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-019-1120-4","volume":"38","author":"Q Huang","year":"2019","unstructured":"Huang Q, et al. Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer. J Exp Clin Cancer Res. 2019;38(1):129.","journal-title":"J Exp Clin Cancer Res"},{"key":"2490_CR38","doi-asserted-by":"publisher","first-page":"176113","DOI":"10.1016\/j.ejphar.2023.176113","volume":"960","author":"J Xiao","year":"2023","unstructured":"Xiao J, et al. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARgamma\/CD36 pathway and altering the gut microbiota. Eur J Pharmacol. 2023;960:176113.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2490_CR39","doi-asserted-by":"publisher","first-page":"20304","DOI":"10.1038\/s41598-019-56835-8","volume":"9","author":"L Souza-Moreira","year":"2019","unstructured":"Souza-Moreira L, et al. Adipose-derived mesenchymal stromal cells modulate lipid metabolism and lipid Droplet Biogenesis via AKT\/mTOR -PPARgamma Signalling in macrophages. Sci Rep. 2019;9(1):20304.","journal-title":"Sci Rep"},{"issue":"6","key":"2490_CR40","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.celrep.2018.10.035","volume":"25","author":"M Aprile","year":"2018","unstructured":"Aprile M, et al. PPARgammaDelta5, a naturally Occurring Dominant-negative splice isoform, impairs PPARgamma function and adipocyte differentiation. Cell Rep. 2018;25(6):1577\u2013e15926.","journal-title":"Cell Rep"},{"key":"2490_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-00793-4_1","volume":"99","author":"AN Gunenc","year":"2022","unstructured":"Gunenc AN, et al. Fatty acid synthase: structure, function, and Regulation. Subcell Biochem. 2022;99:1\u201333.","journal-title":"Subcell Biochem"},{"issue":"5","key":"2490_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","volume":"1821","author":"AP Jensen-Urstad","year":"2012","unstructured":"Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta. 2012;1821(5):747\u201353.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2490_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2490_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1530-0277.1998.tb03868.x","volume":"22","author":"Q Chen","year":"1998","unstructured":"Chen Q, Galleano M, Cederbaum AI. Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P-4502E1. Alcohol Clin Exp Res. 1998;22(4):782\u20134.","journal-title":"Alcohol Clin Exp Res"},{"issue":"51","key":"2490_CR45","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee JY, et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc Natl Acad Sci U S A. 2020;117(51):32433\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"2490_CR46","doi-asserted-by":"publisher","first-page":"132944","DOI":"10.1016\/j.chemosphere.2021.132944","volume":"291","author":"Y Mu","year":"2022","unstructured":"Mu Y, et al. Activation of pyroptosis and ferroptosis is involved in the hepatotoxicity induced by polystyrene microplastics in mice. Chemosphere. 2022;291(Pt 2):132944.","journal-title":"Chemosphere"},{"issue":"11","key":"2490_CR47","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/carcin\/8.11.1619","volume":"8","author":"AB Weitberg","year":"1987","unstructured":"Weitberg AB. Effects of inhibitors of arachidonic acid metabolism and vitamin E on oxygen radical-induced sister chromatid exchanges. Carcinogenesis. 1987;8(11):1619\u201320.","journal-title":"Carcinogenesis"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02490-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02490-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02490-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T10:17:22Z","timestamp":1743329842000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02490-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2490"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02490-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors read the final version and agree to publish it.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}